A critical review of atypical antipsychotic utilization: Comparing monotherapy with polypharmacy and augmentation

Current Medicinal Chemistry

Volumn 11, Issue 3, 2004, Pages 313-327

  Stahl, S M ^a,b   Grady, M M ^a  

^a NEUROSCIENCE EDUCATION INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antipsychotic; Atypical; Augmentation; Polypharmacy

Indexed keywords

ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; BENZATROPINE; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CHLORPROMAZINE; CLOZAPINE; GABAPENTIN; HALOPERIDOL; LAMOTRIGINE; LEVOMEPROMAZINE; LITHIUM; LOXAPINE; OLANZAPINE; PIMOZIDE; QUETIAPINE; RISPERIDONE; SULPIRIDE; THIORIDAZINE; TOPIRAMATE; VALPROATE SEMISODIUM; VALPROIC ACID; ZIPRASIDONE;

AGRANULOCYTOSIS; AKATHISIA; ATAXIA; CARDIOPULMONARY INSUFFICIENCY; CARDIOVASCULAR DISEASE; CATATONIA; CLINICAL TRIAL; COMPULSION; DELIRIUM; DIABETIC KETOACIDOSIS; DISEASE EXACERBATION; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG FATALITY; DRUG MECHANISM; DRUG MEGADOSE; DRUG POTENTIATION; DRUG RESPONSE; DRUG UTILIZATION; DYSTONIA; EDEMA; EXTRAPYRAMIDAL SYMPTOM; HEART ARRHYTHMIA; HEPATIC ENCEPHALOPATHY; HUMAN; HYPERPROLACTINEMIA; HYPERSALIVATION; INCIDENCE; LONG TERM CARE; MONOTHERAPY; MYOCLONUS; NEUROLEPTIC MALIGNANT SYNDROME; NEUROTOXICITY; NEUTROPENIA; OCULOGYRIC CRISIS; ORTHOSTATIC HYPOTENSION; POLYPHARMACY; PRIAPISM; PSYCHOSIS; QT PROLONGATION; RESPIRATION DEPRESSION; REVIEW; SCHIZOPHRENIA; SEDATION; SEIZURE; SEXUAL DYSFUNCTION; SIDE EFFECT; TREMOR;

ACETIC ACIDS; AMINES; ANTICONVULSANTS; ANTIPSYCHOTIC AGENTS; CLINICAL TRIALS; CLOZAPINE; CYCLOHEXANECARBOXYLIC ACIDS; DRUG UTILIZATION; GAMMA-AMINOBUTYRIC ACID; HUMANS; POLYPHARMACY; RISPERIDONE; SCHIZOPHRENIA; VALPROIC ACID;

EID: 1242329378     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/0929867043456070     Document Type: Review

References (173)

1. Tandon, R.; Jibson, M.D. Psychoneuroendocrinology, 2003, 28, 9.
2. Kapur, S.; Remington G. Annu. Rev. Med, 2001, 52, 503.
3. Love, R.C.; Nelson, M.W. Expert Opin. Pharmacother., 2000, 1, 1441.
4. Goodnick, P.J.; Rodriguez, L.; Santano, O. Expert Opin. Pharmacother., 2002, 3, 1381.
5. Tandon, R. Psychiatric Quarterly, 2002, 73, 297.
6. Mahmoud, R.A.; Engelhart, L.M. 21st CINP Congress, 1998, Glasgow, Scotland.
7. Lieberman, J.A.; Koreen, A.R.; Chakos, M.; Sheitman, B.; Woerner, M.; Alvir J.M.J.; Bilder, R. J. Clin. Psychiatry, 1996, 57 (suppl 9), 5.
8. Tran, P.V.; Hamilton, S.H.; Kuntz, A.J.; Potvin, J.H.; Andersen, S.W.; Beasley Jr, C.; Tollefson, G.D. J. Clin. Psychopharmacol., 1997, 17, 407.
9. Stahl, S.M.; Simon-Leack, J.; Walker, V. 42nd NCDEU, 2002, Boca Raton, Fl.
10. Johnsrud, M.; Crismon, M. L.; Thompson, A.; Grogg, A. APA, 2001, New Orleans, La.
11. Chong, S.A.; Remington, G. Schiz. Bulletin, 2000, 26, 421.
12. Freudenreich, O.; Goff, D.C. Acta Psychiatr. Scand., 2002, 106, 323.
13. Citrome, L.; Volavka, J. Harvard Rev. Psychiatry, 2002, 10, 280.
14. Bronson, B.D.; Lindenmayer, J.P. J. Clin. Psychopharmacol., 2000, 20, 382.
15. Heimann, S.W.; Vitiello, B.; Werry, J.S. J. of the American Academy of Child and Adolescent Psychiatry, 1999, 38, 496.
16. Martin, J.; Gomez, J.C.; Garcia-Bernardo, E.; Cuesta, M.; Alvarez, E.; Gurpegui, M. J. Clin. Psychiatty, 1997, 58, 479.
17. Campo, A.; Nijman, H.; Merckelbach, H. Acta Neuropsychiatrica, 1998, 10/3, 78.
18. Conley, R.R.; Tamminga, C.A.; Bartko, J.J.; Richardson, C.; Peszke, M.; Lingle. J.; Hegerty, J.; Love, R.; Gounaris, C.; Zaremba, S. Am. J. Psychiatry, 1998, 155, 914.
19. Alao, A.O.; Armenta, W.A.; Yolles, J.C. Annals of Pharmacotherapy, 1999, 33/11, 1228.
20. Lindenmayer, J.P.; Volavka, H.; Iskander, A.; Parak, M.; Kotsaftis, A.; Czobor, P.; Parker, B. Schizophrenia Research, 1999, 36/1-3, 287.
21. Launer, M.A. Schizophrenia Research, 1998, 29/1-2, 149.
22. McElroy, S.L.; Frye, M.; Denicoff, K.; Altshuler, L.; Nolen, W.; Kupka, R.; Suppes, T.; Keck Jr, P.E.; Leverich, G.S.; Kmetz, G.F.; Post, R.M. Journal of Affective Disorders, 1998, 49/2, 119.
23. Tollefson, G.D.; Birkett, M.A.; Kiesler, G.M.; Wood, A.J. Biol. Psychiatry, 2001, 49, 52.
24. Dursun, S.M.; Gardner, D.M.; Bird, D.C.; Flinn, J. Can. J. Psychiatry, 1999, 44, 701.
25. Sheitman, B.B.; Lindgren, J.C.; Early, J.; Sved, M. Am. J. Psychiatry, 1997, 154, 1626.
26. Mountjoy, C.Q.; Baldacchino, A.M.; Stubbs, J.H. Am. J. Psychiatry, 1999, 156, 158.
27. Reich, J. Am. J. Psychiatry, 1999, 156, 661.
28. Fanous, A.; Lindenmayer, J.P. J. Clin. Psychopharmacol., 1999, 19, 275.
29. Lindenmayer, J.P.; Volavka, J.; Lieberman, J.; Sheitman, B.; Citrome, L.; Chakos M.; Czobor, P.; Parker, B.; Iskander, A. J. Clin. Psychopharmacol., 2001, 21, 448.
30. Volavka, J.; Czobor, P.; Sheitman, B.; Lindenmayer, J.P.; Citrome, L.; McEvoy, J.P.; Cooper, T.B.; Chakos, M.; Lieberman, J.A. Am. J. Psychiatry, 2002, 159, 255.
31. Small, J.G.; Hirsch, S.R.; Arvanitis, L.A.; Miller, B.G.; Link, C.G. Arch Gen. Psychiatry, 1997, 54, 549.
32. Marder, S.R.; Meibach, R.C. Am. J. Psychiatry, 1994, 151, 825.
33. Peuskens, J. Br. J. Psychiatry, 1995, 166, 712.
34. Kapur, S.; Zipursky, R.; Jones, C.; Remington, G.; Houle S. Am. J. Psychiatry, 2000, 157, 514.
35. Kapur, S.; Zipursky, R.B.; Remington, G. Am. J. Psychiatry, 1999, 156, 286.
36. Nyberg, S.; Eriksson, B.; Oxenstierna, G.; Halldin, C.; Farde, L. Am. J. Psychiatry, 1999, 156, 869.
37. Lerner, V.; Chudakova, B.; Kravets, S.; Polyakova, I. Clin. Neuropsychopharmacol., 2000, 5, 284.
38. Centorrino, F.; Eakin, M.; Bahk, W.M.; Kelleher, J.P.; Goren, J.; Salvatore, P.; Egli, S.; Baldessarini, R.J. Am. J. Psychiatry, 2002, 159, 1932.
39. Mantonakis, I.; Kattan, K.; Zervas, I. M. Eur. Neuropsychopharmacol., 1998, 8 (suppl. 2), 233.
40. Seger, A.; Lamberti, J.S. J. Clin. Psychiatry, 2001, 62, 128.
41. Beelen, A.P.; Yeo, K.T.; Lewis, L.D. Hum. Exp. Toxicol., 2001, 20, 215.
42. Chue, P.; Welch, R. Can. J. Psychiatry, 2001, 46, 86.
43. Hedges, D.W.; Jeppson, K.G. Ann. Pharmacother., 2002, 36, 437.
44. Potkin, S.G.; Thyrum, P.T.; Alva, G.; Bera, R.; Yeh, C.; Arvanitis, L.A. J. Clin. Psychopharmacol., 2002, 22, 121.
45. Mauri, M.C.; Bravin, S.; Bitetto, A.; Rudelli, R.; Invernizzi, G. Drug Saf, 1996, 14, 288.
46. Caley, C.F.; Weber, S.S. Ann. Pharmacother., 1995, 29, 152.
47. Raskin, S.; Durst R.; Katz, G.; Zislin, J. J. Clin. Psychopharmacol., 2000, 20, 500.
48. Gomberg, R.F. J. Clin. Psychopharmacol., 1999, 19, 272.
49. Jarventausta, K.; Leinonen, E. Acta Psychiatrica. Scand, 2000, 102, 231.
50. Takhar, J. J. Psychiatry Neurosci., 1999, 24, 248.
51. Goss, LB. Am. J. Health Sys. Pharm., 1995, 52, 1012.
52. Waring, E.W.; Devin, P.G.; Dewan, V. Can. J. Psychiatry, 1999, 44, 189.
53. Witz, S.; Kosov, I.; Assael-Amini, M.; Abramovish, Y. Eur. Neuropsychopharmacol., 2000, 10, 284.
54. Mujica, R.; Weiden, P. Am. J. Psychiatry, 2001, 158, 650.
55. Terao, T.; Kojima, H. J. Neuropsychiatry Clin. Neurosci., 2001, 13, 114.
56. Bacher, N.M.; Kaup, B.A. Am. J. Psychiatry, 1996, 53, 137.
57. Henderson, D.C.; Goff, D.C.; Connolly, C.E.; Borba, C.P.; Hayden, D. J. Clin. Psychiatry, 2001, 62, 605.
58. Henderson, D.C.; Goff, D.C. J. Clin. Psychiatry, 1996, 57, 395.
59. De Groot, I.W.; Heck, A.H.; van Harten, P.N. J. Clin. Psychiatry, 2001, 62, 129.
60. Taylor, C.G.; Flynn, S.W.; Altman, S.; Ehmann, T.; MacEwan, G.W.; Honer, W.G. Schiz. Res., 2001, 48, 155.
61. McCarthy, R.H.; Terkèlsen, K.G. Pharmacopsychiatr, 1995, 28, 61.
62. Patel, J.K.; Salzman, C.; Green, A.L.; Tsuang, M.T. Am. J. Psychiatry, 1997, 154, 543.
63. Tyson, S.C.; Devane, C.L.; Risch, S.C. Am. J. Psychiatry, 1995, 152, 1401.
64. Risch, S.C.; Jackson, C.; Ware, M. 33rd ACNP, 1994, San Juan, Puerto Rico.
65. Morera, A.L.; Barreiro, P.; Cano-Munoz, J.L. Acta Psychiatr. Scand, 1999, 99, 305.
66. Zervas, I.M.; Mantonakis, I.; Kattan, K. Psychopharmaca, 1998, S37.
67. Mantonakis, I.; Kattan, K.; Zervas, I.M. Eur. Neuropsychopharmacol., 1998, 8 (suppl 2), 233.
68. Adesanya, A.; Pantelis, C. Aust. N. Z. J. Psychiatry, 2000, 34, 533.
69. Raju, G.V.L.; Kumar, R.; Khanna, S. Aust. A. Z. J. Psychiatry, 2001, 35, 543.
70. Raskin, S.; Katz, G.; Zislin, Z.; Knobler, H.Y.; Durst, R. Acta Psychiatr. Scand., 2000, 101, 334.
71. Chong, S.A.; Tan, C.H.; Lee, H.S. J. Clin. Psychopharmacol., 1997, 17, 130.
72. Chong, S.A.; Tan, C.H.; Lee, H.S. Can. J. Psychiatry, 1996, 41, 315.
73. Koreen, A.R.; Lieberman, J.A.; Kronig, M.; Cooper, T.B. Am. J. Psychiatry, 1995, 152, 1690.
74. Godleski, L.S.; Sernyak, M.J. Am. J. Psychiatry, 1996, 153, 735.
75. Beauchemin, M.A. Can. J. Psychiatry, 2002, 47, 886.
76. Raaska, K.; Raitasuo, V.; Neuvonen, P.J. Eur. J. Clin. Pharmacol., 2002, 58, 587.
77. Senechal, A.; Landry, P.; Deschamps, R.; Lessard, M. Encephale, 2002, 28, 567.
78. Kontaxakis, V.P.; Havaki-Kontaxakis, B.J.; Stamouli, S.S.; Christodoulou, G.N. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2002, 26, 407.
79. Procyshyn, R.M.; Tse, G.; Sin, O.; Flynn, S. Eur. Neuropsychopharmacol., 2002, 12, 77.
80. Rhoads, E. J. Clin. Psychiatry, 2000, 61, 678.
81. Gupta, S.; Sonnenberg, S.J.; Frank, B. Ann. Clin. Psychiatry, 1998, 10, 113.
82. Kaye, N.S. J. Clin. Psychiatry, 2003, 64, 215.
83. Reinstein, M.J.; Sirotovskaya, L.A.; Jones, L.E.; Mohan, S.; Chasanov, M.A. Clin. Drug Invest., 1999, 18, 99.
84. Diaz, P.; Hogan, T.P. Am. J. Psychiatry, 2000, 158, 651.
85. Shiloh, R.; Zemishlany, D.; Aizenberg, M.; Radwan, B.; Schwartz, P.; Dorfman-Etrog, I.; Modai, M.; Khaikin, M.; Weizman, A. Br. J. Psychiatry, 1997, 171, 569.
86. Potter, W.Z.; Ko, G. N.; Zhang, L.D.; Yan, W. Psychopharmacology, 1989, 99, S87-S97.
87. Friedman, J.; Ault, K.; Powchik, P. Biol. Psychiatry, 1997, 42, 522.
88. Stubbs, J.H.; Haw, C.M.; Staley, C.J.; Mountjoy, C.Q. Acta Psychiatr. Scand., 2000, 102, 390.
89. Mowerman, S.; Siris, S.G. Ann. Clin. Psychiatry, 1996, 8, 193.
90. Allen, S.A. J. Clin. Pharmacol., 2000, 40, 1296.
91. Grohmann, R.; Ruther, E.; Sassim, N.; Schmidt, L.G. Psychopharmacol., 1989, 99, S101.
92. Peacock, L.; Gerlach, J. J. Clin. Psychiatry, 1994, 55, 44.
93. Cooke, C.; de Leon, J. J. Clin. Psychiatry, 1999, 60, 710.
94. Stahl, S.M. J. Clin. Psychiatry, 1999, 60, 425.
95. Stahl, S.M. J. Clin. Psychiatry, 1999, 60, 506.
96. Casey, D.E.; Daniel, D.G.; Wassef, A.A.; Tracy, K.A.; Wozniak, P.; Sommerville, K.W. Neuropyschopharmacol, 2003, 23, 182.
97. Littrell, K.H.; Petty, R.G.; Hilligoss, N.M.; Peabody, C.D.; Johnson, C.G. 41st NCDEU, 2001, Phoenix, AZ.
98. Grove Jr, V.E.; Quintanilla, J.; DeVaney, G.T. New Engl. J. Med., 2000, 343, 973.
99. Sanders, R.D.; Lehrer, D.S. J. Clin. Psychiatry, 1998, 59, 689.
100. Baldassano, C.F.; Ghaemi, S.N. J. Clin. Psychiatry, 1996, 57, 422.
101. Lauterbach, E.C. Neuropsychiatry, Neuropsychology, and Behavioral Neurology, 1998, 11, 157.
102. Chong, S.A.; Tan, C.H.; Lee, E.L.; Liow, P.H. J. Clin. Psychiatry, 1998, 59, 430.
103. Bertoldo, M. J. Am. Acad. Child Adolesc. Psychiatry, 2002, 41, 632.
104. van Watttum, P.J. J. Am. Acad. Child Adolesc. Psychiatry, 2001, 40, 866.
105. Spina, E.; Avenoso, A.; Facciola, G.; Salemi, M.; Scordo, M.G.; Giacobello, T.; Madia, A.G.; Perucca, E. Ther. Drug Monit., 2000, 22, 481.
106. Wirshing, W.C.; Ames, D.; Bisheff, S.; Pierre, J.M.; Mendoza, A.; Sun, A. J. Clin. Psychiatry, 1997, 17, 120.
107. Kando, J.C.; Tohen, M.; Castillo, J.; Centorrino, F. J. Clin. Psychiatry, 1994, 55, 255.
108. Costello, L.E.; Suppes, T. J. Clin. Psychopharmacol., 1995, 15, 139.
109. Madeb, R.; Hirschmann, S.; Kurs, R.; Turkic, A.; Modai, I. Eur. Psychiatry, 2002, 17, 238.
110. Pantelis, C.; Adesanya, A. Aust. N. Z. Psychiatry, 2001, 35, 544.
111. Meltzer, H.Y.; Ranjan, R. Am. J. Psychiatry, 1994, 151, 1246.
112. Norrie, P. Neuropsychopharmacol., 2000, 23(Suppl. 2), S134.
113. Centorrino, F.; Baldessarini, R.J.; Kando, J.; Frankenburg, F.R.; Volpicelli, S.A.; Puopolo, P.R.; Flood, J.G. Am. J. Psychiatry, 1994, 151, 123.
114. Facciola, G.; Avenoso, A.; Scordo, M.G.; Madia, A.G.; Ventimiglia, A.; Perucca, E.; Spina, E. Ther. Drug Monit., 1999, 21, 341.
115. California Department of Health Services, Medi-Cal Program. Atypical antipsychotic educational project: DUR Manual and Educational Articles. Available at: http://files.medical.ca.gov/pubsdoco/dur/dur_edu.asp.
116. Megna, J.L.; Devitt, P.J.; Santo, M.D.; Dewan, M.J. Ann. Pharmacotherapy, 2002, 36, 12.
117. Jablonowski, K.; Margolese, H.C.; Chouinard, G. Can. J. Psychiatry, 2002, 47, 975.
118. Usiskin, S.I.; Nicolson, R.; Lenane, M.; Rapoport, J.L. Am. J. Psychiatry, 2000, 157, 482.
119. Landry, P. Am. J. Psychiatry, 2001, 158, 1930.
120. Matthews, S.C.; Dimsdale, J.E. Psychosomatics, 2001, 42, 280.
121. Spiller, H.A.; Dunaway, M.D.; Cutino, L. Vet. Hum. Toxicol., 2002, 44. 243.
122. Potkin, S.G.; Thyrum, P.T.; Bera, R.; Carreon, D.; Alva, G.; Kalali, A.H.; Yeh, C. Clin. Ther., 2002, 24, 1809.
123. Apseloff, G.; Mullet, D.; Wilner, K.D.; Anziano, R.J.; Tensfeldt, T.G.; Pelletier, S.M.; Gerber, N. Br J. Clin. Pharmacol., 2000, 49 (Suppl. 1), 61.
124. Martin, J.C.; Palenciano, G.; Perez, R. J. Clin. Psychiatry, 2000, 61, 948.
125. Thomas, S.G.; Labbate, L.A. Can. J. Psychiatry, 1998, 43, 195.
126. Gajwani, P. Tesar, G.E. Psychosomatics, 2000, 41, 150.
127. Berry, N.; Pradhan, S.; Sagar, R.; Gupta, S.K. Pharmacotherapy, 2003, 23, 255.
128. Durrenberger, S.; De Leon, J. J. NeuroPsychiatry Clin. Neurosci., 1999, 11, 518.
129. Swanson, C.L; Price, W.A.; McEvoy, J.P. Am. J. Psychiatry, 1995, 152, 1096.
130. Chen, B.; Cardasis, W. Am. J. Psychiatry, 1996, 153, 1233.
131. Owley, T.; Leventhal, B.; Cook JR, E.H. J. Child Adolesc. Psychopharmacol., 2001, 11, 441.
132. Koval, M.S.; Rames, L.J. Am. J. Psychiatry, 1994, 151, 780.
133. Peterson, G.A.; Byrd, S.L. Am. J. Psychiatry, 1996, 153, 737.
134. Garcia, G.; Crismon, M.L; Dorson, P.G. J. Clin. Psychopharmacol., 1994, 14, 426.
135. Blier, P.; Slater, S.; Measham, T.; Kock, M.; Wiviott, G. Int. Clin. Psychopharmacol., 1998, 13, 137.
136. Boshes, R.A.; Manschrenk, T.C.; Desrosiers, J.; Candela, S.; Hanrahan-Boshes, M. Ann. Clin. Psychiatry, 2001, 13, 233.
137. Lee, S.H.; Yang, Y.Y. Zhonghua Yi Xue Za Zhi (Tapei), 1999, 62, 184.
138. Valevski, A.; Modai, I.; Lahav, M.; Weizman, A. Int. Clin. Psychopharmacol., 1993, 8, 63.
139. Tiihonen, J.; Hallikainen, T.; Ryynanen, O.P.; Repo-Tiihonen, E.; Kotilainen, I.; Eronen, M.; Toivonen, P.; Wahlbeck, K.; Putkonen, A. J. Eur. College Neuropsychopharmacol., 2002, 12, S262.
140. Kossen, M.; Selten, J.P.; Kahn, R.S. Am. J. Psychiatry, 2001, 158, 1930.
141. Dursun, S.M.; Deakin, J.F. J. Psychopharmacol., 2001, 15, 297.
142. Damiani, T.; Christensen, R.C. Am. J. Geriatr. Psychiatry, 2000, 8, 346.
143. Saba, G.; Dumortier, G.; Kalalou, K.; Benadhira, R.; Degrassat, K.; Glikman, J.; Januel, D. J. Neuropsychiatry Clin. Neurosci., 2002, 14, 86.
144. Dursun, S.M.; McIntosh, D.; Milliken, H. Arch Gen. Psychiatry, 1999, 56, 950.
145. Dursun, S.M.; Devarajan, S. Can. J. Psychiatry, 2000, 45, 198.
146. Navarro, V.; Pons, A.; Romero, A.; Bernardo, M. Am. J. Psychiatry, 2001, 158, 968.
147. Levy, E.; Margolese, H.C.; Chouinard, G. J. Clin. Psychiatry, 2002, 63, 1045.
148. Leucht, S.; McGrath, J.; White, P.; Kissling, W. J. Clin. Psychiatry, 2002, 63, 218.
149. Lucas, R.A.; Gilfillan, D.J.; Bergstrom, R.F. Eur. J. Clin. Pharmacol., 1998, 54, 639.
150. Olesen, O.V.; Linnet, R. Ther. Drug Monit., 1999, 21, 87.
151. Licht, R.W.; Olesen, O.V.; Friss, P.; Laustsen, R. J. Clin. Psychopharmacol., 2000, 20, 110.
152. Ono, S.; Mihara, K.; Suzuki, A.; Kondo, T.; Yasui-Furukori, N.; Furukori, H.; de Vries, R.; Kaneko, S. Psychopharmacol., 2002, 162, 50.
153. De Leon, J.; Bork, J. J. Clin. Psychiatry, 1997, 58, 450.
154. Spina, E.; Scordo, M.G.; Avenoso, A. J. Clin. Psychophamracol., 2001, 21, 108.
155. Rittmannsberger, H.; Leblhuber, F. Biol. Psychiatry, 1992, 32, 364.
156. Muller, T.; Becker, T.; Fritze, J. Lancet, 1988, 2 (8626-8627), 1500.
157. Gerson, S.L.; Lieberman, J.A.; Friedenberg, W.R.; Lee, D.; Marx, J.J. Jr.; Meltzer, H. Lancet, 1991, 338 (8761), 262.
158. Junghan, U.; Albers, M.; Woggon, B. Pharmacopsychiatry, 1993, 26, 262.
159. Hollister, L.E.; Muller-Oerlinghausen, B.; Rickels, K.; Shader, R.I. J. Clin. Psychopharmacol., 1993, 13 (Suppl. 1), 72.
160. Wolkowitz, O.M.; Pickar, D. Am. J. Psychiatry, 1991, 148, 714.
161. Sassim, N.; Grohmann, R. Pharmacopsychiatry, 1988, 21, 306.
162. Grohmann, R.; Ruther, E.; Sassim, N.; Schmidt, L.G. Psychopharmacology, 1989, 99 (suppl), 101.
163. Cobb, C.D.; Anderson, C.B.; Seidel, D.R, Am. J. Psychiatry, 1991, 148, 1606.
164. Klimke, A.; Klieser, E. Am. J. Psychiatry, 1994, 151, 780.
165. Jackson, C.W.; Markowitz, J.S.; Brewerton, T.D. Ann. Clin. Psychiatry, 1995, 7, 139.
166. Bredbacka, P.E.; Paukkula, E.; Kinnunen, E.; Koponen, H. Int. Clin. Psychopharmacol., 1993, 8, 205.
167. Sachs, G.S.; Grossman, F.; Ghaemi, S.N.; Okamoto, A.; Bowden, C.L. Am. J. Psychiatry, 2002, 159, 1146.
168. Yatham, L.N.; Grossman, F.; Augustyns, I.; Vieta, E.; Rayindran, A. Br. J. Psychiatry, 2003, 182, 141.
169. Simpson, G.; Potkin, S.; Weiden, P.; O'Sullivan, R.L. J. Eur. College Neuropsychopharmacol., 2000, 10, S289.
170. Casey, D.E.; Carson, W.H.; Saha, A.R.; Liebeskind, A.; Ali, M.W.; Jody, D.; Ingenitoon, G.G. Psychopharmacol., 2003, 166, 391.
171. Texas Implementation of Medication Antipsychotic Algorithm. Available at http://www.mhmr.state.tx.us/centraloffice/medicaldirector/tima.html
172. Stahl, S.M. J. Clin. Psychiatry, 2002, 63, 93.
173. Stahl, S.M.; Simon-Leack, J.; Walker,V. 23rd CINP, 2002, Montreal, Canada.